SCHEMBL18630261

SCHEMBL18630261

CC(C)(I)C(=O)CCC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 6/20 0.47
LMNA P02545 4/20 0.47
ALKBH5 Q6P6C2 1/20 0.47
SUCNR1 Q9BXA5 1/20 0.47
SLC15A2 Q16348 1/20 0.43
FFAR3 O14843 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
MAPK1 P28482 1/20 0.38
SLC13A3 Q8WWT9 1/20 0.38
OR51E2 Q9H255 1/20 0.38
PHF8 Q9UPP1 6/20 0.37
KDM2A Q9Y2K7 6/20 0.37
KDM5C P41229 4/20 0.37
KDM4E B2RXH2 3/20 0.37
KDM6B O15054 3/20 0.37
SLC22A6 Q4U2R8 1/20 0.36
HMGCR P04035 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20976453 0.85 SLC22A6 (0.52) LMNAOR51E2SLC22A6TSHRNFKB1
SCHEMBL409946 0.78 EGLN1 (0.53) EGLN1LMNAALKBH5SUCNR1SLC15A2
SCHEMBL21776012 0.74 LMNA (0.47) EGLN1LMNAALKBH5SUCNR1SLC15A2
SCHEMBL10369361 0.74 EGLN1 (0.47) EGLN1LMNAALKBH5SUCNR1SLC15A2
SCHEMBL18630072 0.73 TSHR (0.35) TSHR
Succinic Acid SCHEMBL8052773 0.73 EGLN1 (0.75) EGLN1LMNAALKBH5SUCNR1SLC15A2
SCHEMBL9837882 0.72 LMNA (0.48) EGLN1LMNAALKBH5SUCNR1SLC15A2
SCHEMBL25407021 0.70 CAMK2A (0.46) EGLN1LMNAALKBH5SUCNR1SLC15A2
SCHEMBL21087207 0.70 FAAH (0.40) LMNASLC22A6TSHRNFKB1PMP22
Succinic Acid SCHEMBL3628497 0.69 EGLN1 (0.82) EGLN1LMNAALKBH5SUCNR1SLC15A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170073370-A1 BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. 2017-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170073370-A1 BROAD SPECTRUM ANTIBIOTICS SPAST, NPEPPS, SPOUT1 EGLN1 737/4885LMNA 1941/4885ALKBH5 1083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.